On January 7, the government approved the emergency use of the Oxford-AstraZeneca Covid-19 vaccine.
The approval will allow Beximco Pharmaceuticals to bring doses from the Serum Institute of India, which is manufacturing the vaccine, Mohammad Salahuddin, deputy director of the Directorate General of Drug Administration (DGDA), said.
Under the deal, Bangladesh will import 3 crore doses of SARS-Cov-2 AZD 1222 (Oxford-Astrazeneca vaccine) from Serum in the next six months.
“If everything goes well, we will get the vaccines in mid-January,” Health Minister Zahid Maleques said.
On December 28, Bangladeshi pharmaceutical company Globe Biotech got approval from the DGDA for manufacturing Covid-19 vaccine for clinical trials.
“Bangladesh currently has the capacity to store up to 150 million vaccines. So, there won’t be any issues when 40-50 million doses come from India,” he told the media after a meeting of the ministry on vaccination and distribution.
Minister Maleque is fully prepared for the vaccination drive. “Vaccination will be carried out from the public hospitals,” he said.
“Each government hospital has been prepared to preserve 425,000 doses. Another 71,000 doses can be stored in the five-six ice freezers at the hospitals,” the minister said.